Results 81 to 90 of about 3,242 (120)

Association of immune checkpoint inhibitors with muscle mass and density in patients with melanoma. [PDF]

Oncologist
Ziolkowski S, Matheson BE, Boyd SK, Walle M, Gill J, Walker J, Salopek T, Baker JF, Fettahoglu A, Ye C.   +9 more
europepmc   +1 more source

Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades. [PDF]

Oncologist
Jamal F, Sahvan O, Junior PLSU, Jones JC, Ou FS, Bekaii-Saab T, Sonbol MB.   +6 more
europepmc   +1 more source

First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer. [PDF]

Oncologist
Nasca V, Tinè G, Taieb J, Lonardi S, Boursi B, Margalit O, Salvatore L, Cohen R, Ros J, Ambrosini M, Zwart K, Roodhart J, Jayachandran P, Overman MJ, Elez ME, Cremolini C, Tougeron D, Koopman M, André T, Miceli R, Pietrantonio F.   +20 more
europepmc   +1 more source

Complete remission following pembrolizumab in a man with mCRPC with both microsatellite instability and BRCA2 mutation. [PDF]

Oncologist
Moore C, Naraine I, Zhang T.
europepmc   +1 more source

Pancreatic cancer cell-intrinsic transglutaminase-2 promotes T cell suppression through microtubule-dependent secretion of immunosuppressive cytokines. [PDF]

J Immunother Cancer
Lahusen A, Minhöfer N, Lohse KA, Blechner C, Lindenmayer J, Eiseler T, Wellstein A, Kleger A, Seufferlein T, Windhorst S, Lin YN.   +10 more
europepmc   +1 more source

The Portormin (Dunbeath) Runestone

Futhark: International Journal of Runic Studies, 2016
Martin Findell
doaj  

Runes and Editors: The Changing Face of Corpus Editions

Futhark: International Journal of Runic Studies, 2010
Michael P. Barnes
doaj  

N 244 Helland II: A Topsy-turvy Runestone

Futhark: International Journal of Runic Studies, 2013
James E. Knirk
doaj